|
10 Dec 2007 |
Sangamo BioSciences Announces Presentation of Data for ZFP Therapeutic for Glioblastoma at American Society for Hematology Meeting
|
|
10 Dec 2007 |
Osiris Therapeutics Reports Positive Results for Prochymal(TM) as
|
|
05 Dec 2007 |
Senesco Technologies Initiates Preclinical Studies for Cancer Target
|
|
04 Dec 2007 |
Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
|
|
03 Dec 2007 |
Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Assessment of Its Phase I/II Trial of tgAAC94 for Inflammatory Arthritis
|
|
28 Nov 2007 |
Geron initiates clinical trial of telomerase inhibitor drug in patients with multiple myeloma
|
|
27 Nov 2007 |
Osiris Therapeutics Announces Positive One Year Data from Chondrogen Trial for Knee Repair
|
|
27 Nov 2007 |
Amsterdam Molecular Therapeutics Initiates Program for Late Stage Liver Cirrhosis
|
|
27 Nov 2007 |
Isis and Excaliard Collaborate to Develop Antisense Drugs for Local Treatment of Fibrotic Diseases
|
|
26 Nov 2007 |
Targeted Genetics Announces That FDA Has Removed Hold on Phase I/II Clinical Trial of tgAAC94 for Inflammatory Arthritis
|
|
20 Nov 2007 |
Covalon Achieves Important Milestone in Its Cell-Based Gene Therapy for Treating Congestive Heart Failure and Tissue Regeneration
|
|
19 Nov 2007 |
Quark Announces First Systemic siRNA Dosing
|
|
19 Nov 2007 |
Meyer Pharmaceuticals acquires NF-kappa b decoy technology for treatment of inflammatory disease
|
|
15 Nov 2007 |
Athersys IND for MultiStem Authorized for Phase I Clinical Trial in Bone Marrow Transplant Support
|
|
15 Nov 2007 |
Thallion Announces Positive Safety and Efficacy Data From ECO-4601 Phase I/II Trial
|
|
14 Nov 2007 |
Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer
|
|
14 Nov 2007 |
Cardium Initiates Phase 2b Excellarate Clinical Study for Diabetic Ulcers
|
|
14 Nov 2007 |
Invitrogen and CytRx Subsidiary RXi Pharmaceuticals Collaborate to Enhance RNAi Technologies for Therapeutic Applications
|
|
13 Nov 2007 |
Isis Reports New Data for Mipomersen in Routine High Cholesterol Patients and Provides Cumulative Safety Summary
|
|
13 Nov 2007 |
Introgen and Gendux Submit First Marketing Authorization Application for ADVEXIN
|
|
13 Nov 2007 |
Archemix Announces Initiation of Phase 2a Trial for Aptamer Product Candidate ARC1779 in Patients with Acute Coronary Syndrome
|
|
10 Nov 2007 |
Targeted Genetics Announces Positive Interim Phase I/II Results for tgAAC94 in Inflammatory Arthritis
|
|
07 Nov 2007 |
Data show Geron’s cell-based therapeutic for spinal cord injury survives and exhibits remyelination for at least nine months following injection
|
|
07 Nov 2007 |
Fresenius Medical Care Announces Continued Positive Data from
|
|
07 Nov 2007 |
Sangamo BioSciences Announces ZFP Therapeutic Data From Nerve Regeneration Program at Society for Neuroscience Meeting
|
